Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Besinger

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Klinische Wochenschrift|September 17, 1979
[The significance of determining antibodies to acetylcholine receptor in myasthenia gravis (author's transl)]K V Toyka, T Becker, A Fateh-Moghadam, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 1980
Passively transferred myasthenia gravis: protection of mouse endplates by Fab fragments from human myasthenic IgGK V Toyka, B Löwenadler, K Heininger, et al.
Muscle & Nerve|July 1, 1982
Plasma exchange in chronic inflammatory polyneuropathy: evidence suggestive of a pathogenic humoral factorK V Toyka, R Augspach, H Wiethölter, et al.
Journal of the Neurological Sciences|October 1, 1984
Chronic inflammatory polyneuropathy. Reduction of nerve conduction velocities in monkeys by systemic passive transfer of immunoglobulin GK Heininger, U G Liebert, K V Toyka, et al.
Deutsche Medizinische Wochenschrift (1946)|May 6, 1983
[Immunogenetics of myasthenia gravis. Significance of HLA-, complement and Cm gene systems for clinical and immunologic parameters]H Grosse-Wilde, K V Toyka, U A Besinger, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Klinische Wochenschrift|September 17, 1979
[The significance of determining antibodies to acetylcholine receptor in myasthenia gravis (author's transl)]K V Toyka, T Becker, A Fateh-Moghadam, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 1980
Passively transferred myasthenia gravis: protection of mouse endplates by Fab fragments from human myasthenic IgGK V Toyka, B Löwenadler, K Heininger, et al.
Muscle & Nerve|July 1, 1982
Plasma exchange in chronic inflammatory polyneuropathy: evidence suggestive of a pathogenic humoral factorK V Toyka, R Augspach, H Wiethölter, et al.
Journal of the Neurological Sciences|October 1, 1984
Chronic inflammatory polyneuropathy. Reduction of nerve conduction velocities in monkeys by systemic passive transfer of immunoglobulin GK Heininger, U G Liebert, K V Toyka, et al.
Deutsche Medizinische Wochenschrift (1946)|May 6, 1983
[Immunogenetics of myasthenia gravis. Significance of HLA-, complement and Cm gene systems for clinical and immunologic parameters]H Grosse-Wilde, K V Toyka, U A Besinger, et al.
Pageof 2